-
17:55
001 5924514 -
17:49
001 5924956
-
17:43
001 5924851
-
17:38
001 5924929
-
17:32
001 5924913
-
17:22
56452 Podcast 56452
-
17:21
001 5924921
-
17:10
Practical Risk Assessment for AKT Inhibitor 54762
-
17:00
001 5924910
-
16:51
001 5924911
-
16:44
001 5924957
-
16:38
001 5924908
-
16:27
IL 51037
-
16:26
001 5924923
-
16:16
001 5924909
-
16:04
Personalizing Systemic Therapy in Atopic Dermatitis and Prurigo Nodularis 51039
-
15:03
Beyond IOP: Integrating Ocular Surface Resilience Into Glaucoma Management 49097
-
14:44
7708 allen green 10262015 7708
-
14:29
4599 Parker Hill 4599
-
14:15
12180 podcast 12180
-
14:00
7053 Pickard Silver 08252014 7053
-
13:54
001 5925040
-
13:44
001 5923389
-
13:30
The Mechanistic Case for Dual BAFF and APRIL Inhibition in IgAN 60616
-
13:25
001 5923475
-
13:21
001 5924187
-
13:16
001 5924015
-
13:04
Key CKD Updates from the 2026 NKF Meetings 49276
-
12:59
001 5924252
-
12:45
Connecting Chronic Kidney Disease and Cardiovascular Risk in Primary Care 54800
-
12:41
001 5924063
-
12:36
001 5924488
-
12:31
001 5924036
-
12:25
001 5924486
-
12:14
56452 Podcast 56452
-
12:02
50890podcast 50890
-
11:46
29905 podcast 29905
-
11:41
001 5923391
-
11:36
001 5924492
-
11:33
001 5924578
-
11:32
001 5924923
-
11:27
001 5924825
-
11:12
Progress in Breast Cancer Care: Translating SABCS Data Into Practice 48989
-
10:58
Targeting B7 36232
-
10:44
Examining the Global Genetic Prevalence of TK2d 54413
-
10:38
001 5924955
-
10:33
001 5925036
-
10:20
Integrating Patient Perspectives in Dermatologic Care 37245
-
10:09
Practical Risk Assessment for AKT Inhibitor 54762
-
09:51
54582 podcast 54582
-
09:39
Hypertension Across Diverse Populations: Practical Strategies for Equitable Care 56369
-
08:37
36607 podcast v1 MM 36607
-
08:32
001 5924686
-
08:31
001 5920947
-
07:47
39877 audio 39877
-
07:42
001 5924017
-
07:28
36270 Audio 36270
-
07:23
001 5924813
-
06:59
Advancing Care in ER+/HER2− ESR1m mBC: What EMERALD and Real 35866
-
06:53
001 5924487
-
06:44
001 5925046
-
06:35
001 5924788
-
06:23
Case Consult: Personalizing First 60963
-
06:05
Rewriting the Calcium Code in ADH1 54833
-
05:55
Axatilimab's Impact on cGVHD and Associated BOS 54341
-
05:42
Key CKD Updates from the 2026 NKF Meetings 49276
-
05:40
001 5925049
-
05:39
001 5920139
-
05:33
001 5925058
-
05:27
001 5923849
-
05:24
001 5923848
-
05:20
001 5925057
-
05:09
56452 Podcast 56452
-
05:04
001 5925056
-
04:53
Practical Risk Assessment for AKT Inhibitor 54762
-
04:42
Real 54340
-
04:39
001 5924611
-
04:38
001 5920146
-
04:33
001 5924700
-
04:28
001 5924620
-
04:27
001 5924923
-
04:22
001 5923852
-
04:18
001 5924183
-
04:16
001 5924682
-
04:05
36271 Podcast 36271
-
04:00
001 5924494
-
03:45
36270 Audio 36270
-
03:41
001 5924649
-
03:38
001 5924807
-
03:37
001 5920361
-
03:30
001 5924721
-
03:26
001 5924195
-
03:17
001 5924809
-
03:00
Rewriting the Calcium Code in ADH1 54833
-
02:59
001 5924920
-
02:56
001 5924917
-
02:45
Axatilimab's Impact on cGVHD and Associated BOS 54341
-
02:40
001 5924215
-
02:35
001 5924497
-
02:32
001 5924193
-
02:27
001 5924619
-
02:26
001 5924922
-
02:21
001 5924824
-
02:09
Key CKD Updates from the 2026 NKF Meetings 49276
-
02:08
001 5924921
-
01:58
56452 Podcast 56452
-
01:47
Practical Risk Assessment for AKT Inhibitor 54762
-
01:42
001 5924718
-
01:31
Real 54340
-
01:26
001 5924393
-
01:03
36523 podcast 36523
-
00:59
001 5924222
-
00:45
36270 Audio 36270